(redirected from Intragastric Balloon)
Also found in: Dictionary, Thesaurus, Medical, Legal, Encyclopedia.

Balloon Loan

A loan or bond in which the borrower makes only interest payments for a set period of time. At the end of the term, the borrower repays the entire principal at once. A balloon loan may be useful when the borrower expects interest rates to be low at the end of the term, allowing him/her simply to refinance the loan. However, there is a high risk of default because not all borrowers actually have the cash to repay an entire loan in one payment. See also: Balloon Mortgage.


The loan balance remaining at the time the loan contract calls for full repayment.

References in periodicals archive ?
Intragastric balloon in the treatment of super-morbid obesity.
Experience with sedation technique for intragastric balloon placement and removal.
Intragastric balloons intended for weight loss consist of one or more balloons that are placed into the stomach through the mouth using a minimally invasive endoscopic procedure while the patient is under mild sedation.
s Orbera Intragastric Balloon to assist adult patients suffering from obesity in losing and maintaining weight, the company said on Thursday.
Another procedure that is increasingly being used is intragastric balloon, which is basically a short-term solution, but yields rapid results.
ClickPress, Mon Jul 01 2013] Weight Loss/Obesity Management Market - [Meal Replacements, Slimming Centers, Nutrition & Psychological Consultancy, Treadmill, Ellipticals, Strength Training, Gastric Bypass, Intragastric Balloon System, Stomaphyx] - Global Forecasts To 2017
This is because the risk of surgery is lower for this patient segment and technological innovations such as gastric surgery (GS) and intragastric balloon (IB) devices can be effectively applied to them.
The acquisition builds upon the strength of Allergan's existing obesity intervention product portfolio, which includes the LAP-BAND([R]) Adjustable Gastric Banding System, currently the only adjustable implant device for individualized weight loss approved in the United States and a leading bariatric procedure worldwide; and the BIB(TM) BioEnterics([R]) Intragastric Balloon, a non-surgical alternative for the treatment of obesity approved in many countries although not currently available in the United States.
Some of the devices in the experimental stages include the implantable gastric stimulator and the intragastric balloon.
Key clinical development programs include the Hylaform regulatory submission, the botulinum toxin type A program and key product development initiatives in support of the Company's obesity intervention products, the LAP-BAND System and the BioEnterics(R) Intragastric Balloon (BIB).